CHECK OUT IG They have a huge pipeline and they're submitting ANDA's at a fast rate. Though the products don't have the same market size as IPCI's drugs, they are consistently growing and will most likely hit a profit next quarter for the first time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.